1208170-17-5Relevant articles and documents
Design, synthesis, and antihypertensive activity of new pyrimidine derivatives endowing new pharmacophores
Farghaly, Ahmed M.,AboulWafa, Omaima M.,Elshaier, Yaseen A. M.,Badawi, Waleed A.,Haridy, Haridy H.,Mubarak, Heba A. E.
, p. 360 - 379 (2019)
A new series of achiral pyrimidine derivatives based on nifedipine-like structure was designed and synthesized. These pyrimidyl derivatives contained hydrazine, hydrazones, acetohydrazide, differently substituted benzylidene functionalities, benzosulfohyd
An efficient and practical synthesis of 2,4-substituted pyrido[4,3-d]pyrimidin-5(6H)-ones
Tian, Xinrong,Suarez, Dominic P.,Li, William Hoi Hong,McSherry, Allison K.,Sanchez, Robert M.,Moore, Michael L.,Axten, Jeffrey M.
, (2019/11/13)
We describe an efficient synthesis of 2,4-substituted pyrido[4,3-d]pyrimidin-5(6H)-ones, which involves the acid-promoted cyclization of cyano enamine 15 to afford 2,4-bis(methylthio)pyrido[4,3-d]pyrimidin-5(6H)-one 17 as a key intermediate. Selective displacement of the 4-methylthio group by a wide range of anilines followed by oxidation of the 2-methylthio group and subsequent substitution by amines enabled the synthesis of a variety of 2,4-disubstituted pyrido[4,3-d]pyrimidin-5(6H)-ones.
BICYCLIC INHIBITORS OF ALK
-
, (2014/06/25)
The present invention relates to compounds of formula (1) or pharmaceutical acceptable salts, Formula (1) wherein R1, R2, R3, X, Y, Z, A, B, G1, m, and n are defined in the description. The present invention relates also to compositions containing said compounds which are useful for inhibiting kinases such as ALK and methods of treating diseases such as cancer.
BICYCLIC INHIBITORS OF ALK
-
, (2012/08/07)
The present invention relates to compounds of formula (1) or pharmaceutical acceptable salts, Formula (1) wherein R1, R2, R3, X, Y, Z, A, B, G1, m, and n are defined in the description. The present invention relates also to compositions containing said compounds which are useful for inhibiting kinases such as ALK and methods of treating diseases such as cancer.
CHEMICAL COMPOUNDS
-
Page/Page column 55, (2010/04/03)
The invention is directed to pyrido[4,3-d]pyrimidin-5(6H)-one derivatives. Specifically, the invention is directed to compounds according to Formula (I) wherein R1, R2, R3, and R4 are defined below. The compound